|
1
|
Sulis G, Centis R, Sotgiu G, D'Ambrosio L,
Pontali E, Spanevello A, Matteelli A, Zumla A and Migliori GB:
Recent developments in the diagnosis and management of
tuberculosis. NPJ Prim Care Respir Med. 26:160782016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Raviglione M and Sulis G: Tuberculosis
2015: Burden, challenges and strategy for control and elimination.
Infect Dis Rep. 8:65702016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
de Jonge MI, Brosch R, Brodin P, Demangel
C and Cole ST: Tuberculosis: From genome to vaccine. Expert Rev
Vaccines. 4:541–551. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang L, Ru HW, Chen FZ, Jin CY, Sun RF,
Fan XY, Guo M, Mai JT, Xu WX, Lin QX and Liu J: Variable virulence
and efficacy of BCG vaccine strains in mice and correlation with
genome polymorphisms. Mol Ther. 24:398–405. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bali P, Tousif S, Das G and Van Kaer L:
Strategies to improve BCG vaccine efficacy. Immunotherapy.
7:945–948. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ahmed MM, Velayati AA and Mohammed SH:
Epidemiology of multidrug-resistant, extensively drug resistant,
and totally drug resistant tuberculosis in middle east countries.
Int J Mycobacteriol. 5:249–256. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Odone A, Matteelli A, Chiesa V, Cella P,
Ferrari A, Pezzetti F, Signorelli C and Getahun H: Assessing the
impact of defining a global priority research agenda to address
HIV-associated tuberculosis. Trop Med Int Health. 21:1420–1427.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cardona PJ: The progress of therapeutic
vaccination with regard to tuberculosis. Front Microbiol.
7:15362016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bhargava S, Choubey S and Mishra S:
Vaccines against tuberculosis: A review. Indian J Tuberc. 63:13–18.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schnepp BC and Johnson PR: Vector-mediated
in vivo antibody expression. Microbiol Spectr. 2:AID–0016-2014.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang E, Wang F, Xu Y, Wang H, Hu Y, Shen H
and Chen ZW: A lentiviral vector-based therapeutic vaccine encoding
Ag85B-Rv3425 potently increases resistance to acute tuberculosis
infection in mice. Acta Biochim Biophys Sin (Shanghai). 47:588–596.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dheda K, Barry CE III and Maartens G:
Tuberculosis. Lancet. 387:1211–1226. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang E, Gu J, Wang F, Wang H, Shen H and
Chen ZW: Recombinant BCG prime and PPE protein boost provides
potent protection against acute Mycobacterium tuberculosis
infection in mice. Microb Pathog. 93:1–7. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang J, Qie Y, Zhang H, Zhu B, Xu Y, Liu
W, Chen J and Wang H: PPE protein (Rv3425) from DNA segment RD11 of
Mycobacterium tuberculosis: A novel immunodominant antigen of
Mycobacterium tuberculosis induces humoral and cellular immune
responses in mice. Microbiol Immunol. 52:224–230. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang J, Qie Y, Liu W and Wang H:
Protective efficacy of a recombinant BCG secreting antigen
85B/Rv3425 fusion protein against Mycobacterium tuberculosis
infection in mice. Hum Vaccin Immunother. 8:1869–1874. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang E, Lu Y, Xu Y, Liang Q, Wang C, Wang
H and Shen H: Recombinant BCG coexpressing Ag85B, ESAT-6 and
Rv3620c elicits specific Th1 immune responses in C57BL/6 mice.
Microb Pathog 69–70. 1–59. 2014.
|
|
17
|
Shen H, Wang Y, Chen CY, Frencher J, Huang
D, Yang E, Ryan-Payseur B and Chen ZW: Th17-related cytokines
contribute to recall-like expansion/effector function of
HMBPP-specific Vγ2Vδ2 T cells after Mycobacterium tuberculosis
infection or vaccination. Eur J Immunol. 45:442–451. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shen H, Wang C, Yang E, Xu Y, Liu W, Yan
J, Wang F and Wang H: Novel recombinant BCG coexpressing Ag85B,
ESAT-6 and mouse TNF-alpha induces significantly enhanced cellular
immune and antibody responses in C57BL/6 mice. Microbiol Immunol.
54:435–441. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim JS, Kim WS, Choi HG, Jang B, Lee K,
Park JH, Kim HJ, Cho SN and Shin SJ: Mycobacterium tuberculosis
RpfB drives Th1-type T cell immunity via a TLR4-dependent
activation of dendritic cells. J Leukoc Biol. 94:733–749. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pontali E, Sotgiu G, Centis R, D'Ambrosio
L, Spanevello A and Migliori GB: Management of drug resistantTB in
patients with HIV co-infection. Expert Opin Pharmacother.
16:2737–2750. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Abate G and Hoft DF: Immunotherapy for
tuberculosis: Future prospects. Immunotargets Ther. 5:37–45.
2016.PubMed/NCBI
|
|
22
|
Palavecino CE, Céspedes PF, Gómez RS,
Kalergis AM and Bueno SM: Immunization with a recombinant bacillus
Calmette-Guerin strain confers protective Th1 immunity against the
human metapneumovirus. J Immunol. 192:214–223. 2014. View Article : Google Scholar : PubMed/NCBI
|
